Device for treating gait deficit caused by multiple sclerosis receives FDA marketing authorisation

Retrieved on: 2021-06-15 17:03:45

Tags for this article:

Click the tags to see associated articles and topics

Device for treating gait deficit caused by multiple sclerosis receives FDA marketing authorisation. View article details on hiswai:

Excerpt

Cambridge Consultants, part of Capgemini, and Helius Medical Technologies, Inc (NASDAQ:HSDT), have confirmed that a groundbreaking device ...

Article found on: www.cambridgenetwork.co.uk